Browse by Phase
Phase 1 / Phase 2 Clinical Trials
Phase 1/2 combined trials evaluate both safety (Phase 1) and preliminary efficacy (Phase 2) in a single study protocol, often used to accelerate early development.
Total Trials
374
Recruiting Now
374
Top Conditions in Phase 1 / Phase 2
NCT06834035 Phase 1, Phase 2
Recruiting
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullos...
Condition
Epidermolysis Bullosa
Enrollment
8 pts
Location
United States
Sponsor
M. Peter Marinkovich
NCT07301710 Phase 1, Phase 2
Recruiting
Low-Tech Treatments for Obstructive Sleep Apnea
Condition
Obstructive Sleep Apnea (OSA)
Enrollment
60 pts
Location
United States
Sponsor
Uniformed Services University
NCT06138743 Phase 1, Phase 2
Recruiting
Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy
Condition
Myotonic Dystrophy 1
Enrollment
78 pts
Location
Australia, New Zealand, Taiwan
Sponsor
Arrowhead Pharmaceuticals
NCT06778850 Phase 1, Phase 2
Recruiting
A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses o...
Condition
Overweight and Obese Volunteers
Enrollment
131 pts
Location
China
Sponsor
MindRank AI Ltd
NCT05218889 Phase 1, Phase 2
Recruiting
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metasta...
Condition
Pancreatic Cancer
Enrollment
90 pts
Location
China
Sponsor
Chinese PLA General Hospital
NCT06880913 Phase 1, Phase 2
Recruiting
Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL
Condition
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Enrollment
50 pts
Location
China
Sponsor
Peking University People's Hos
NCT07396155 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy i...
Condition
Diabetic Nephropathy Type 2
Enrollment
10 pts
Location
Indonesia
Sponsor
PT. Prodia Stem Cell Indonesia
NCT05263960 Phase 1, Phase 2
Recruiting
A Study of CM350 in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
248 pts
Location
China
Sponsor
Keymed Biosciences Co.Ltd
NCT07220668 Phase 1, Phase 2
Recruiting
Sense4Safety Intervention
Condition
Mild Cognitive Impairment
Enrollment
200 pts
Location
United States
Sponsor
University of Pennsylvania
NCT05481879 Phase 1, Phase 2
Recruiting
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DY...
Condition
Myotonic Dystrophy Type 1 (DM1)
Enrollment
116 pts
Location
United States, Australia, France
Sponsor
Dyne Therapeutics
NCT05660980 Phase 1, Phase 2
Recruiting
Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virolog...
Condition
HIV-1-infection
Enrollment
90 pts
Location
United States, Botswana, Brazil
Sponsor
National Institute of Allergy
NCT05989841 Phase 1, Phase 2
Recruiting
Mitigating PTSD-CUD After Sexual Assault
Condition
Posttraumatic Stress Disorder
Enrollment
68 pts
Location
United States
Sponsor
University of Nevada, Las Vega
NCT05445154 Phase 1, Phase 2
Recruiting
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed...
Condition
Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment
58 pts
Location
China
Sponsor
CSPC ZhongQi Pharmaceutical Te
NCT06678113 Phase 1, Phase 2
Recruiting
Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With I...
Condition
Invasive Fungal Infection
Enrollment
15 pts
Location
India
Sponsor
Biosergen AS
NCT07208773 Phase 1, Phase 2
Recruiting
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
260 pts
Location
China
Sponsor
MediLink Therapeutics (Suzhou)
NCT07180927 Phase 1, Phase 2
Recruiting
DLL3 CAR-T Therapy Targeting Brain Tumors
Condition
Glioblastoma of Cerebellum
Enrollment
30 pts
Location
China
Sponsor
Shenzhen Geno-Immune Medical I
NCT00967785 Phase 1, Phase 2
Recruiting
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
Condition
Leukopenia
Enrollment
20 pts
Location
United States
Sponsor
National Institute of Allergy
NCT04924491 Phase 1, Phase 2
Recruiting
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Re...
Condition
Heart Transplantation
Enrollment
11 pts
Location
Spain
Sponsor
Rafael Correa-Rocha
NCT06700538 Phase 1, Phase 2
Recruiting
Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus
Condition
Obesity
Enrollment
120 pts
Location
New Zealand
Sponsor
Arrowhead Pharmaceuticals
NCT07291076 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combina...
Condition
Hepatocellular Carcinoma (HCC)
Enrollment
129 pts
Location
United States, Australia, Chile
Sponsor
Bristol-Myers Squibb
NCT06617793 Phase 1, Phase 2
Recruiting
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB...
Condition
Relapsing Multiple Sclerosis
Enrollment
28 pts
Location
Australia, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT03836950 Phase 1, Phase 2
Recruiting
rTMS to Improve Cognition in Parkinson's
Condition
Parkinson's Disease
Enrollment
56 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07250750 Phase 1, Phase 2
Recruiting
A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia G...
Condition
Myasthenia Gravis
Enrollment
96 pts
Location
United States, Bulgaria, Italy
Sponsor
ImmunAbs Inc.
NCT07340697 Phase 1, Phase 2
Recruiting
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
Condition
Actinic Keratosis (AK)
Enrollment
24 pts
Location
United States
Sponsor
Rubedo Life Sciences, Inc.
NCT03294889 Phase 1, Phase 2
Recruiting
ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
Condition
Prostate Cancer
Enrollment
45 pts
Location
Switzerland
Sponsor
University Hospital, Geneva